|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,310.00 JPY | +0.35% |
|
+1.49% | +13.35% |
| 06-25 | Declaration of Voting Results by Asuka Pharmaceutical | CI |
| 05-27 | Dalton Investment strongly oppose conditional activation of countermeasures announced by ASKA Pharmaceutical Holdings on May 25 | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Stocks
- 4886 Stock
- Consensus ASKA Pharmaceutical Holdings Co.,Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
